AGT and metabolic syndrome: Features of metabolic syndrome, such as adiposity, NAFLD, hypertension, hyperglycemia and dyslipidemia may modulate liver fibrosis (i.e., NASH) through hepatic stellate cell activation stimulated by advanced glycation end product, macrophage infiltration, promotion of inflammation, leptin, angiotensin II, and oxidative stress [14].